Does this patient have a severe upper gastrointestinal bleed?
Srygley FD, Gerardo CJ, Tran T, Fisher DA.
JAMA. 2012 Mar 14;307(10):1072-9. doi: 10.1001/jama.2012.253.
PMID:22416103
Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.
Crombie N, Doughty HA, Bishop JRB, Desai A, Dixon EF, Hancox JM, Herbert MJ, Leech C, Lewis SJ, Nash MR, Naumann DN, Slinn G, Smith H, Smith IM, Wale RK, Wilson A, Ives N, Perkins GD; RePHILL collaborative group.
Lancet Haematol. 2022 Apr;9(4):e250-e261. doi: 10.1016/S2352-3026(22)00040-0. Epub 2022 Mar 7.
Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
Gil H, Bouldoires B, Bailly B, Meaux Ruault N, Humbert S, Magy-Bertrand N.
Rev Med Interne. 2019 Mar;40(3):173-177. doi: 10.1016/j.revmed.2018.11.008. Epub 2018 Nov 27.
PMID:30501929
Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study.
de Vos TW, Winkelhorst D, Porcelijn L, Beaufort M, Oldert G, van der Bom JG, Lopriore E, Oepkes D, de Haas M, van der Schoot E.
Lancet Haematol. 2023 Dec;10(12):e985-e993. doi: 10.1016/S2352-3026(23)00271-5. Epub 2023 Oct 27.
PMID:38407610
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N, Zhao H, Churilov L, Wu TY, Ma H, Nguyen HT, Cheung A, Meretoja A, Mai DT, Kleinig T, Jeng JS, Choi PMC, Duc PD, Brown H, Ranta A, Spratt N, Cloud GC, Wang HK, Grimley R, Mahawish K, Cho DY, Shah D, Nguyen TMP, Sharma G, Yogendrakumar V, Yan B, Harrison EL, Devlin M, Cordato D, Martinez-Majander N, Strbian D, Thijs V, Sanders LM, Anderson D, Parsons MW, Campbell BCV, Donnan GA, Davis SM; STOP-MSU Trial Investigators.